Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 2 (2005), Issue 5 (May)

1. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
   Magn Reson Imaging, 23(3): 469-74. [Abstract] [Full-text]
2. Quantification of multiple sclerosis lesion load and brain tissue volumetry using multiparameter MRI: methodology and reproducibility.
   Magn Reson Imaging, 23(3): 445-52. [Abstract] [Full-text]
3. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis.
   Neuroimage, 26(1): 258-65. [Abstract] [Full-text]
4. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.
   J Clin Invest, 115(5): 1352-60. [Abstract] [Full-text]
5. Mortality of multiple sclerosis in Spain: demonstration of a north-South gradient.
   Neuroepidemiology, 24(3): 135-40. [Abstract] [Full-text]
6. Mortality trends of multiple sclerosis in Spain, 1951-1997: an age-period-cohort analysis.
   Neuroepidemiology, 24(3): 129-34. [Abstract] [Full-text]
7. Cytokines in multiple sclerosis: from bench to bedside.
   Pharmacol Ther, 106(2): 163-77. [Abstract] [Full-text]
8. Emerging properties of cannabinoid medicines in management of multiple sclerosis.
   Trends Neurosci, 28(5): 272-6. [Abstract] [Full-text]
9. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.
   Proc Natl Acad Sci U S A, 102(18): 6449-54. [Abstract] [Full-text]
10. Multiple sclerosis: diagnosis and the management of acute relapses.
    Postgrad Med J, 81(955): 302-8. [Abstract] [Full-text]
11. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis.
    Arch Neurol, 62(5): 803-8. [Abstract] [Full-text]
12. Kinin B1 receptor expression on multiple sclerosis mononuclear cells: correlation with magnetic resonance imaging T2-weighted lesion volume and clinical disability.
    Arch Neurol, 62(5): 795-800. [Abstract] [Full-text]
13. Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
    Arch Neurol, 62(5): 785-92. [Abstract] [Full-text]
14. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients.
    Arch Neurol, 62(5): 714-7. [Abstract] [Full-text]
15. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression.
    J Neuroimmunol, 163(1): 172-8. [Abstract] [Full-text]
16. IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
    J Neuroimmunol, 163(1): 165-71. [Abstract] [Full-text]
17. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
    Neuropathol Appl Neurobiol, 31(3): 292-303. [Abstract] [Full-text]
18. Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone).
    Eur J Neurol, 12(6): 425-31. [Abstract] [Full-text]
19. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
    Rev Med Virol, 15(3): 179-211. [Abstract] [Full-text]
20. Taking part in life: enhancing participation in multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 583-94. [Abstract] [Full-text]
21. Mitigating the impact of multiple sclerosis on employment.
    Phys Med Rehabil Clin N Am, 16(2): 571-82, x-xi. [Abstract] [Full-text]
22. Health promotion in people with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 557-70. [Abstract] [Full-text]
23. Exercise and rehabilitation for individuals with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 513-55. [Abstract] [Full-text]
24. Chronic pain in persons with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 503-12. [Abstract] [Full-text]
25. Multiple sclerosis-related fatigue.
    Phys Med Rehabil Clin N Am, 16(2): 483-502. [Abstract] [Full-text]
26. Multiple sclerosis and spasticity.
    Phys Med Rehabil Clin N Am, 16(2): 467-81. [Abstract] [Full-text]
27. A practical approach to immunomodulatory therapy for multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 449-66, ix. [Abstract] [Full-text]
28. Depression in persons with multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 437-48, ix. [Abstract] [Full-text]
29. Neuropsychological evaluation and treatment of multiple sclerosis: the importance of a neuro-rehabilitation focus.
    Phys Med Rehabil Clin N Am, 16(2): 411-36, viii. [Abstract] [Full-text]
30. MRI in multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 383-409, viii. [Abstract] [Full-text]
31. Diagnosing multiple sclerosis and its imitators.
    Phys Med Rehabil Clin N Am, 16(2): 359-81. [Abstract] [Full-text]
32. Multiple sclerosis: an immunologic perspective.
    Phys Med Rehabil Clin N Am, 16(2): 351-8. [Abstract] [Full-text]
33. Epidemiology and etiology of multiple sclerosis.
    Phys Med Rehabil Clin N Am, 16(2): 327-49. [Abstract] [Full-text]
34. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
    NMR Biomed, 18(3): 173-85. [Abstract] [Full-text]
35. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.
    Brain, 128: 1454-60. [Abstract] [Full-text]
36. Cigarette smoking and the progression of multiple sclerosis.
    Brain, 128: 1461-5. [Abstract] [Full-text]
37. Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis?
    Arch Dis Child, 90(6): 636-9. [Abstract] [Full-text]
38. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.
    Lancet Neurol, 4(6): 341-8. [Abstract] [Full-text]
39. Functionality or aesthetics? A pilot study of music therapy in the treatment of multiple sclerosis patients.
    Complement Ther Med, 13(1): 25-33. [Abstract] [Full-text]
40. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis.
    Neurosci Lett, 382(1): 82-7. [Abstract] [Full-text]
41. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    JAMA, 293(20): 2496-500. [Abstract] [Full-text]
42. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients.
    J Magn Reson Imaging, 21(6): 735-43. [Abstract] [Full-text]
43. Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.
    J Magn Reson Imaging, 21(6): 669-75. [Abstract] [Full-text]
44. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis.
    Magn Reson Med, 53(6): 1415-22. [Abstract] [Full-text]
45. Assessment of multiple sclerosis lesions with spherical harmonics: comparison of MR imaging and pathologic findings.
    Radiology, 235(3): 1036-44. [Abstract] [Full-text]
46. Lack of serum oligoclonal antibody responses to Chlamydophila pneumoniae in multiple sclerosis.
    Eur Neurol, 53(2): 81-3. [Abstract] [Full-text]
47. Clinical multiple sclerosis occurs at one end of a spectrum of CNS pathology: a modified threshold liability model leads to new ways of thinking about the cause of clinical multiple sclerosis.
    Med Hypotheses, 65(2): 232-7. [Abstract] [Full-text]
48. A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis.
    Neurol Sci, 26: s150-1. [Abstract] [Full-text]

© 2004-2010 Multiple Sclerosis Research Today. All Rights Reserved.